Biochemical, Physiological, and Pathological Aspects of the Peripheral Benzodiazepine Receptor
1992; Wiley; Volume: 58; Issue: 5 Linguagem: Inglês
10.1111/j.1471-4159.1992.tb10030.x
ISSN1471-4159
AutoresMoshe Gavish, Yeshayahu Katz, Shalom Bar‐Ami, Ronit Weizman,
Tópico(s)Cholinesterase and Neurodegenerative Diseases
ResumoJournal of NeurochemistryVolume 58, Issue 5 p. 1589-1601 Biochemical, Physiological, and Pathological Aspects of the Peripheral Benzodiazepine Receptor Moshe Gavish, Corresponding Author Moshe Gavish Rappapport Family Institute for Research in the Medical Sciences and Department of Pharmacology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of TechnologyAddress correspondence and reprint requests to Dr. M. Gavish at Department of Pharmacology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O. Box 9649, 31096 Haifa, Israel.Search for more papers by this authorYeshayahu Katz, Yeshayahu Katz Rappapport Family Institute for Research in the Medical Sciences and Department of Pharmacology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of TechnologySearch for more papers by this authorShalom Bar-Ami, Shalom Bar-Ami Department of Obstetrics and Gynecology, Rambam Medical Center, HaifaSearch for more papers by this authorRonit Weizman, Ronit Weizman Tel Aviv Community Mental Health Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this author Moshe Gavish, Corresponding Author Moshe Gavish Rappapport Family Institute for Research in the Medical Sciences and Department of Pharmacology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of TechnologyAddress correspondence and reprint requests to Dr. M. Gavish at Department of Pharmacology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O. Box 9649, 31096 Haifa, Israel.Search for more papers by this authorYeshayahu Katz, Yeshayahu Katz Rappapport Family Institute for Research in the Medical Sciences and Department of Pharmacology, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of TechnologySearch for more papers by this authorShalom Bar-Ami, Shalom Bar-Ami Department of Obstetrics and Gynecology, Rambam Medical Center, HaifaSearch for more papers by this authorRonit Weizman, Ronit Weizman Tel Aviv Community Mental Health Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSearch for more papers by this author First published: May 1992 https://doi.org/10.1111/j.1471-4159.1992.tb10030.xCitations: 127Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES Amiri Z., Weizman R., Katz Y., Burstein O., Edoute Y., Lochner A., and Gavish M. (1991) Testosterone and cyproterone acetate modulate peripheral but not central benzodiazepine receptors in rat. Brain Res. 553, 155– 158. Anderson R. A. and Mitchell R. (1984) Benzodiazepines potentiate the effect of muscimol on prolactin secretion in vitro. Br. J. Pharmacol. 82, 343P. Anholt R. R. H. (1986) Mitochondrial benzodiazepine receptors as potential modulators of intermediary metabolism. Trends Pharmacol. Sci. 12, 506– 511. Anholt R. R. H., De Souza E. B., Kuhar M. J., and Snyder S. H. (1985) Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur. J. Pharmacol. 110, 41– 46. Anholt R. R. H., Aebi U., Pederson P. L., and Snyder S. H. (1986a) Solubilization and reassembly of the mitochondrial benzodiazepine receptor. Biochemistry 25, 2120– 2125. Anholt R. R. H., Pedersen P. L., De Souza E. B., and Snyder S. H. (1986b) The peripheral-type benzodiazepine receptor: localization to the mitochondrial outer membrane. J. Biol. Chem. 261, 576– 583. Antkiewicz-Michaluk L., Guidotti A., and Krueger K. E. (1988a) Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Mol. Pharmacol. 34, 272– 278. Antkiewicz-Michaluk L., Mukhin A. G., Guidotti A., and Krueger K. E. (1988b) Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites. J. Biol. Chem. 263, 17317– 17321. Arguelles A. E. and Rosher J. (1975) Diazepam and plasma testosterone levels. Lancet 2, 607. Awad M. and Gavish M. (1987) Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J. Neurochem. 49, 1407– 1414. Awad M. and Gavish M. (1988) Differential effect of detergents on [3H]Ro 5-4864 and [3H]PK 11195 binding to peripheral-type benzodiazepine-binding sites. Life Sci. 43, 167– 175. Awad M. and Gavish M. (1989a) Species differences and heterogeneity of solubilized peripheral-type benzodiazepine binding sites. Biochem. Pharmacol. 38, 3843– 3849. Awad M. and Gavish M. (1989b) Solubilization of peripheral-type benzodiazepine binding sites from cat cerebral cortex. J. Neurochem. 52, 1880– 1885. Awad M. and Gavish M. (1991) Peripheral-type benzodiazepine receptors in human cerebral cortex, kidney, and colon. Life Sci. 49, 1155– 1161. Bar-Ami S., Fares F., and Gavish M. (1989) Effect of hypophysectomy and hormone treatment on the induction of peripheral-type benzodiazepine binding sites in female rat genital axis. Horm. Metab. Res. 21, 106– 107. Bar-Ami S., Fares F., and Gavish M. (1991) Altered peripheral benzodiazepine receptor density in human granulosa-lutein cells in relation to follicular maturity. Mol. Cell. Endocrinol. 82, 285– 291. Barnea E. R., Fares F., and Gavish M. (1989) Modulatory action of benzodiazepines on human term placental steroidogenesis in vitro. Mol. Cell. Endocrinol. 64, 155– 159. Basile A. S. and Skolnick P. (1988) Tissue-specific regulation of "peripheral-type" benzodiazepine receptor density after chemical sympathectomy. Life Sci. 42, 273– 283. Basile A. S., Paul S. M., and Skolnick P. (1985) Adrenalectomy reduces the density of peripheral-type binding sites for benzodiazepines in the rat kidney. Eur. J. Pharmacol. 110, 149– 150. Basile A. S., Klein D. C., and Skolnick P. (1986) Characterization of benzodiazepine receptors in the bovine pineal gland: evidence for the presence of an atypical binding site. Mol. Brain Res. 1, 127– 135. Basile A. S., Weissman B. A., and Skolnick P. (1987) Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex. Brain Res. Bull. 19, 1– 7. Beaumont K., Cheung A. K., Geller M. L., and Fanestil D. D. (1983) Inhibitors of peripheral-type benzodiazepine receptors present in human urine and plasma ultrafiltrates. Life Sci. 33, 1375– 1384. Beaumont K., Healy D. P., and Fanestil D. D. (1984) Autoradiographic localization of benzodiazepine receptors in the rat kidney. Am. J. Physiol. 247, F718– F724. Benavides J., Malgouris C., Imbault F., Begassat F., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., and Le Fur G. (1983a) Peripheral-type benzodiazepine binding sites in rat adrenal: binding studies with [3H]PK 11195 and autoradiographic localization. Arch. Int. Pharmacodyn. Ther. 226, 38– 49. Benavides J., Quarteronet D., Imbault F., Malgouris C., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., and Le Fur G. (1983b) Labeling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem. 41, 1744– 1750. Benavides J., Begassat F., Phan T., Tur C., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., and Le Fur G. (1984a) Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, Ro 5-4864, of the peripheral benzodiazepine receptors. Life Sci. 35, 1249– 1256. Benavides J., Savaki H. E., Malgouris C., Laplace C., Daniel M., Begassat F., Desban M., Uzan A., Dubroeucq M. C., Renault C., Gueremy C., and Le Fur G. (1984b) Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195. Brain Res. Bull. 13, 69– 77. Benavides J., Manager J., Burgevin M. C., Ferris O., Uzan A., Gueremy C., Renault C., and Le Fur G. (1985a) Characterization of solubilized "peripheral-type" benzodiazepine binding sites from rat adrenal gland using [3H]PK 11195, an isoquinoline carboxamide derivative. Biochem. Pharmacol. 34, 167– 170. Benavides J., Vaucher N., Daniel M., Malgouris C., Doble A., Uzan A., Gueremy C., and Le Fur G. (1985b) Peripheral benzodiazepine binding sites in human brain. (Abstr) Soc. Neurosci. Abstr. 11, 278. Bender A. S. and Hertz L. (1985) Pharmacological evidence that the nonneuronal diazepam binding site in primary cultures of glial cells is associated with a calcium channel. Eur. J. Pharmacol. 110, 287– 288. Bisserbe J. C., Patel J., and Eskay R. L. (1986) Evidence that the peripheral-type benzodiazepine receptor ligand Ro 5-4864 inhibits β-endorphin release from AtT-20 cells by blockade of voltage-dependent calcium channels. J. Neurochem. 47, 1419– 1424. Bolger G. T., Newman A. H., Rice K. C., Lueddens H. W. M., Basile A. S., and Skolnick P. (1989) Characterization of the effects of AHN 086, an irreversible ligand of "peripheral" benzodiazepine receptors, on contraction in guinea-pig atria and ileal longitudinal smooth muscle. Can. J. Physiol. Pharmacol. 67, 126– 134. Braestrup C. and Squires R. F. (1977) Specific benzodiazepine receptors in rat brain characterized by high-affinity [3H]diazepam binding. Proc. Natl. Acad. Sci. USA 74, 3805– 3809. Brown C. and Martin I. L. (1984) Autoradiographic localisation of benzodiazepine receptors in the rat pituitary gland. Eur. J. Pharmacol. 102, 563– 564. Bruni G., Dal-Pray P., Dotti M. T., and Segri G. (1980) Plasma ACTH and cortisol levels in benzodiazepine-treated rats. Pharmacol. Res. Commun. 12, 163– 165. Cantor E. H., Kenessey A., Semenuk G., and Spector S. (1984) Interaction of calcium channel blockers with non-neuronal benzodiazepine binding sites. Proc. Natl. Acad. Sci. USA 81, 1549– 1552. Clanachan A. S. and Marshall R. J. (1980) Diazepam potentiates the coronary vasodilator actions of adenosine in anaesthetized dogs. Br. J. Pharmacol. 70, 66P– 67P. Clarke G. D. and Ryan P. J. (1980) Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells. Nature 287, 160– 161. Cohen M. R., Pickar D., and Dubois M. (1981) Surgical stress and endorphins. Lancet 1, 213– 214. Cook P. S., Notelovitz M., Kalra P. S., and Kalra S. P. (1979) Effect of diazepam on serum testosterone and the ventral prostate gland in male rats. Arch. Androl. 3, 31– 35. Curran T. and Morgan J. I. (1985) Superinduction of c-fos by nerve growth factor in the presence of peripherally active benzodiazepines. Science 229, 1265– 1268. Cymerman V., Pazo S. A., and Palacios J. M. (1986) Evidence for species differences in "peripheral" benzodiazepine receptors: an autoradiographic study. Neurosci. Lett. 66, 153– 158. Dar D. E., Weizman A., Karp L., Grinshpoon A., Bidder M., Kotler M., Tyano S., Bleich A., and Gavish M. (1991) Platelet peripheral benzodiazepine receptors in repeated stress. Life Sci. 48, 341– 346. Davies L. P. and Huston V. (1981) Peripheral benzodiazepine binding sites in heart and their interaction with dipyridamole. Eur. J. Pharmacol. 73, 209– 211. De Souza E. B., Anholt R. R. H., Murphy K. M. M., Snyder S. H., and Kuhar M. J. (1985) Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis. Endocrinology 116, 567– 573. Doble A., Benavides J., Ferris O., Bertrand P., Menager J., Vaucher N., Burgevin M.-C., Uzan A., Gueremy C., and Le Fur G. (1985) Dihydropyridine and peripheral-type benzodiazepine binding sites: subcellular distribution and molecular size determination. Eur. J. Pharmacol. 119, 153– 167. Doble A., Ferris O., Burgevin M. C., Menager J., Uzan A., Dobroeucq M. C., Renault C., Gueremy C., and Le Fur G. (1987) Photoaffinity labeling of peripheral-type benzodiazepine-binding sites. Mol. Pharmacol. 31, 42– 49. Drugan R. C., Basile A. S., Crawley J. N., Paul S. M., and Skolnick P. (1986) Inescapable shock reduces [3H]Ro 5-4864 binding to "peripheral-type" benzodiazepine receptors in the rat. Pharmacol. Biochem. Behav. 24, 1673– 1677. Drugan R. C., Basile A. S., Crawley J. N., Paul S. M., and Skolnick P. (1987) "Peripheral" benzodiazepine binding sites in Maudsley reactive rats: selective decrease confined to peripheral tissues. Brain Res. Bull. 18, 143– 145. Elgoyhen B. and Adler-Graschinsky E. (1989) Diminution by benzodiazepines of the chronotropic responses to noradrenaline in rat isolated atria. Eur. J. Pharmacol. 164, 467– 478. Fares F. and Gavish M. (1986) Characterization of peripheral benzodiazepine binding sites in human term placenta. Biochem. Pharmacol. 35, 227– 230. Fares F., Bar-Ami S., Brandes J. M., and Gavish M. (1987a) Gonadotropin- and estrogen-induced peripheral-type benzodiazepine binding sites in the hypophyseal-genital axis of rats. Eur. J. Pharmacol. 133, 97– 102. Fares F., Weizman A., Zlotogorski D., and Gavish M. (1987b) Ontogenesis of peripheral-type benzodiazepine binding sites in rat brain, lung, and heart. Brain Res. 408, 381– 384. Fares F., Bar-Ami S., Haj-Yehia Y., and Gavish M. (1989) Hormonal regulation of peripheral benzodiazepine binding sites in female rat adrenal gland and kidney. J. Recept. Res. 9, 143– 157. Ferrarese C., Appollonio I., Frigo M., Perego M., Riolti R., Trabucchi M., and Frattola L. (1990) Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment. Acta Psychiatr. Scand. 82, 169– 173. File S. and Lister R. G. (1983) The anxiogenic action of Ro 5-4864 is reversed by phenytoin. Neurosci. Lett. 35, 93– 96. French J. F. and Matlib M. A. (1988a) Identification of a high-affinity peripheral-type benzodiazepine binding site in rat aortic smooth muscle membranes. J. Pharmacol. Exp. Ther. 247, 23– 28. French J. F. and Matlib M. A. (1988b) The inhibitory effects of peripheral-type benzodiazepine specific ligands on vascular smooth muscle contraction are unrelated to their high-affinity binding sites. (Abstr) FASEB J. 2, A786. Gavish M. and Fares F. (1985a) The effect of freezing and thawing or of detergent treatment on peripheral benzodiazepine binding: the possible existence of an endogenous ligand. Eur. J. Pharmacol. 107, 283– 284. Gavish M. and Fares F. (1985b) Solubilization of peripheral benzodiazepine binding sites from rat kidney. J. Neurosci. 5, 2889– 2893. Gavish M., Okun F., Weizman A., and Youdim M. B. H. (1986) Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment. Eur. J. Pharmacol. 127, 147– 151. Gavish M., Weizman A., Youdim M. B. H., and Okun F. (1987) Regulation of central and peripheral benzodiazepine receptors in progesterone-treated rats. Brain Res. 409, 386– 390. Gehlert D. R., Yamamura H. I., and Wamsley J. K. (1983) Auto-radiographic localization of "peripheral" benzodiazepine binding sites in the rat brain and kidney using [3H]Ro 5-4864. Eur. J. Pharmacol. 95, 329– 330. Gehlert D. R., Yamamura H. I., and Wamsley J. K. (1985) Auto-radiographic localization of "peripheral" benzodiazepine binding sites in the rat brain, heart, and kidney. Naunyn Schmiedebergs Arch. Pharmacol. 328, 454– 460. Grandison L. (1983) Action of benzodiazepines on the neuroendocrine system. Neuropharmacology 22, 1505– 1510. Grupp I. L., French J. F., and Matlib M. A. (1987) Benzodiazepine Ro 5-4864 increases coronary flow. Eur. J. Pharmacol. 143, 143– 147. Guidotti A., Forchetti C. M., Corda M. G., Konkel D., Bennet C. D., and Costa E. (1983) Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on BDZ receptors. Proc. Natl. Acad. Sci. USA 80, 3531– 3533. Hirsch J. D., Beyer C. F., Malkowitz L., Beer B., and Blum A. (1988) Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol. Pharmacol. 34, 157– 163. Junck L., Olson J. M. M., Ciliax B. J., Koeppe R. A., Watkins G. L., Jewett D. M., McKeever P. E., Wieland D. M., Kilbourn M. R., Starosta-Rubinstein S., Mancini W. R., Kuhl D. E., Greenberg H. S., and Young A. B. (1989) PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann. Neurol. 26, 752– 758. Karp L., Weizman A., Tyano S., and Gavish M. (1989) Examination stress, platelet peripheral benzodiazepine binding sites, and plasma hormone levels. Life Sci. 44, 1077– 1082. Katz Y., Eitan A., Amiri Z., and Gavish M. (1988) Dramatic increase in peripheral benzodiazepine binding sites in human colonic carcinoma as compared to normal colon. Eur. J. Pharmacol. 148, 483– 484. Katz Y., Moskovitz B., Levin D. R., and Gavish M. (1989a) Absence of peripheral-type benzodiazepine binding sites in renal cell carcinoma: a potential biochemical marker. Br. J. Urol. 63, 124– 127. Katz Y., Weizman A., and Gavish M. (1989b) Ligands specific to peripheral benzodiazepine receptors for treatment of porphyria. Lancet 1, 932– 933. Katz Y., Allon N., Abraham S., Oz N., and Gavish M. (1990a) Characterization of partially purified peripheral benzodiazepine binding inhibitor from human cerebrospinal fluid (CSF): its ar-rhythmogenic effects in the rat, in Calcium Channel Modulators in Heart and Smooth Muscle: Basic Mechanisms and Pharmacological Aspects ( S. Abraham and G. Amitai, eds), pp. 253– 268. VCH, Weinheim and Balaban , Rehovot . Katz Y., Amiri Z., Weizman A., and Gavish M. (1990b) Identification and distribution of peripheral benzodiazepine binding sites in male rat genital tract. Biochem. Pharmacol. 40, 817– 820. Katz Y., Ben-Baruch G., Kloog Y., Menczer J., and Gavish M. (1990c) Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin. Sci. 78, 155– 158. Katz Y., Eitan A., and Gavish M. (1990d) Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology 47, 139– 142. Larcher J.-C., Vayssiere J.-L., Le Marquer F. J., Cordeau L. R., Keane P. E., Bachy A., Gros F., and Croizat B. P. (1989) Effect of peripheral benzodiazepines upon the O2 consumption of neuroblastoma cells. Eur. J. Pharmacol. 161, 197– 202. Le Fur G., Perrier M. L., Vaucher N., Imbault F., Flamier A., Benavides J., Uzan A., Renault C., Dubroeucq M. C., and Gueremy C. (1983a) Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinoline carboxamide. Life Sci. 32, 1839– 1847. Le Fur G., Vaucher N., Perrier M. L., Flamier A., Benavides J., Renault C., Dubroeucq M. C., Gueremy C., and Uzan A. (1983b) Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]Ro 5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci. 33, 449– 457. Levy R. I. (1982) Prevalence and epidemiology of cardiovascular disease, in Cecil's Textbook of Medicine ( J. B. Wyngaarden and L. H. Smith, eds), pp. 98– 101. W. B. Saunders, Philadelphia . Mantione C. R., Weissman B. A., Goldman M. E., Paul S. M., and Skolnick P. (1986) Endogenous inhibitors of 4′-[3H]chlorodiazepam (Ro 5-4864) binding to "peripheral" sites for benzodiazepines. FEBS Lett. 176, 69– 74. Mantione C. R., Goldman M. E., Martin B., Bolger G. T., Lueddens H. W. M., Paul S. M., and Skolnick P. (1988) Purification and characterization of an endogenous protein modulator of radio-ligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sites. Biochem. Pharmacol. 37, 339– 347. Marc V. and Marselli P. L. (1969) Effect of diazepam on plasma corticosterone levels in the rat. J. Pharm. Pharmacol. 21, 784– 786. Marthy J., Guazit R., and Lefevre P. (1986) Effects of diazepam and midazolam on baroreflex control of heart rate and on sympathetic activity in humans. Anesth. Analg. 65, 113– 119. Martini C., Giannaccini G., and Lucacchini A. (1983) Solubilization of rat kidney benzodiazepine binding sites. Biochim. Biophys. Acta 728, 289– 292. Matthew E., Laskin J. D., Zimmerman E. A., Weinstein I. B., Hsu K. C., and Engelhardt D. L. (1981) Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 malanoma cells. Proc. Natl. Acad. Sci. USA 78, 3935– 3939. McCabe R. T., Schoenheimer J. A., Skolnick P., Newman A. H., Rice K. C., Reig J.-A., and Klein D. C. (1989) [3H]AHN 086 acylates peripheral benzodiazepine receptors in the rat pineal gland. FEBS Lett. 244, 263– 267. McEnery M. W., Snowman A. M., and Snyder S. H. (1989) Resolution and identification of the putative subunits of the peripheral benzodiazepine receptor of rat kidney mitochondria. (Abstr) Soc. Neurosci. Abstr. 15, 642. Mestre M., Carriot T., Belin C., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., and Le Fur G. (1984) Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sci. 35, 953– 962. Mestre M., Bouetard G., Uzan A., Gueremy C., Renault C., Dubroeucq M. C., and Le Fur G. (1985) PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog. Eur. J. Pharmacol. 112, 257– 260. Mestre M., Belin C., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., and Le Fur G. (1986) Modulation of voltage-operated, but not receptor-operated, calcium channels in the rabbit aorta by PK 11195, an antagonist of peripheral-type benzodiazepine receptors. J. Cardiovasc. Pharmacol. 8, 729– 734. Mizoule J., Gauthier A., Uzan A., Renault C., Dubroeucq M., Gueremy C., and Le Fur G. (1985) Opposite effects of two ligands for peripheral-type benzodiazepine binding sites, PK 11195 and Ro 5-4864, in a conflict situation in the rat. Life Sci. 36, 1059– 1068. Morgan J. I., Johnson M. D., Wang J. K. T., Sonnenfeld K. H., and Spector S. (1985) Peripheral-type benzodiazepines influence or-nithine decarboxylase levels and neurite outgrowth in PC12 cells. Proc. Natl. Acad. Sci. USA 82, 5223– 5226. Noel G. L., Suh H. K., Stone J. C., and Frantz A. G. (1972) Human prolactin and growth hormone release during surgery and other conditions of stress. J. Clin. Endocrinol. 35, 840– 851. Okun F., Weizman R., Katz Y., Bomzon A., Youdim M. B. H., and Gavish M. (1988) Increase in central and peripheral benzodiazepine receptors following surgery. Brain Res. 458, 31– 36. Olson J. M. M., Ciliax B. J., Mancini W. R., and Young A. B. (1988) Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur. J. Pharmacol. 152, 47– 53. Papart P., Ansseau M., Cerfontaine J. L., and Von Frenckell R. (1988) Pilot study of 52028 RP (PK 11195), an antagonist of the peripheral-type benzodiazepine binding sites, among inpatients with anxious or depressive symptomatology. Psychopharmacology (Berlin) 96 (Suppl 1), 219. Pawlikowski M., Lyson K., Kunert-Radek J., and Stepien H. (1988) Effect of benzodiazepines on the proliferation of mouse spleen lymphocytes in vitro. J. Neural Transm. 73, 161– 166. Quirion R. (1984) High density of [3H]Ro 5-4864 peripheral benzodiazepine binding sites in the pineal gland. Eur. J. Pharmacol. 102, 559– 560. Regan J. W., Yamamura H. I., Yamada S., and Roeske W. R. (1981) High-affinity renal [3H]flunitrazepam binding: characterization, localization, and alterations in hypertension. Life Sci. 28, 991– 998. Richfield E. K., Ciliax B. J., Starosta-Rubinstein S. R., McKeever P. E., Penney J. B., and Young A. B. (1988) Comparison of [14C]deoxyglucose metabolism and peripheral benzodiazepine receptor binding in rat C6 glioma. Neurology 38, 1255– 1262. Riond J., Mattei M. G., Kaghad M., Dumont X., Guillemot J. C., Le Fur G., Caput D., and Ferrara P. (1991) Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur. J. Biochem. 195, 305– 311. Ritta M. N. and Calandra R. S. (1989) Testicular interstitial cells as target for peripheral benzodiazepines. Neuroendocrinology 49, 262– 266. Ritta M. N., Campos M. B., and Calandra R. S. (1987) Effect of GABA and benzodiazepines on testicular androgen production. Life Sci. 40, 791– 798. Ruiz F., Hernandez J., and Perez D. (1989) The effect of diazepam on ventricular automaticity induced by a local injury: evidence of involvement of "peripheral type" benzodiazepine receptors. J. Pharm. Pharmacol. 41, 306– 310. Saano V., Raty M., and MacDonald E. (1989) Effect of peripheral benzodiazepine receptor ligands on the contraction of isolated heart atrium and papillary muscle of rats. Pharmacol. Toxicol. 64, 147– 149. Schoemaker H., Bliss M., and Yamamura H. I. (1981) Specific high-affinity saturable binding of [3H]Ro 5-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur. J. Pharmacol. 71, 173– 175. Shibata H., Kojima I., and Ogata E. (1986) Diazepam inhibits potassium-induced aldosterone secretion in adrenal glomerulosa cells. Biochem. Biophys. Res. Commun. 135, 994– 999. Skolnick P. and Paul S. M. (1982) Molecular pharmacology of the benzodiazepines. Int. Rev. Neurobiol. 23, 103– 125. Skowronski R., Fanestil D. D., and Beaumont K. (1988) Photoaffinity labeling of peripheral-type benzodiazepine receptors in rat kidney mitochondria with [3H]PK 14105. Eur. J. Pharmacol. 148, 187– 193. Snyder S. H., Verma A., and Trifiletti R. R. (1987) The peripheral-type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. FASEB J. 1, 282– 288. Snyder S. H., McEnery M. W., and Verma A. (1989) Molecular mechanisms of peripheral benzodiazepine receptors. Neurochem. Res. 15, 119– 123. Sprengel R., Werner P., Seebury P. H., Mukhin A. G., Santi M. R., Grayson D. R., Guidotti A., and Krueger K. E. (1989) Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. J. Biol. Chem. 264, 20415– 20421. Starosta-Rubinstein S. R., Ciliax B. J., Penney J. B., McKeever P. E., and Young A. B. (1987) Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc. Natl. Acad. Sci. USA 84, 891– 895. Stepien H., Pawlikowska A., and Pawlikowski M. (1988) Effects of benzodiazepines on thymus cell proliferation. Thymus 12, 117– 121. Tallman J. F., Paul S. M., Skolnick P., and Gallager D. W. (1980) Receptors for the age of anxiety: pharmacology of benzodiazepines. Science 207, 274– 281. Thuillez J., Loueslati H., Duhaze P., and Giudicelli J. F. (1989) Functional antagonism between PK 11195, a peripheral benzodiazepine receptor antagonist, and nicardipine at the vascular level in healthy subjects: a peripheral hemodynamic study. J. Cardiovasc. Pharmacol. 13, 307– 313. Trifiletti R. R., Verma A., and Snyder S. H. (1986) Molecular identification of peripheral-type benzodiazepine receptors. (Abstr) Soc. Neurosci. Abstr. 12, 666. Verma A. and Snyder S. H. (1989) Peripheral-type benzodiazepine receptors. Annu. Rev. Pharmacol. Toxicol. 29, 307– 322. Wang J. K. T. Taniguchi T., and Spector S. (1980) Properties of [3H]diazepam binding on rat blood platelets. Life Sci. 27, 1881– 1888. Wang J. K. T., Morgan J. I., and Spector S. (1984a) Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl. Acad. Sci. USA 81, 753– 756. Wang J. K. T., Morgan J. I., and Spector S. (1984b) Differentiation of Friend erythroleukemia cells induced by benzodiazepines. Proc. Natl. Acad. Sci. USA 81, 3770– 3772. Weiland G. A., Minneman K. P., and Molinoff P. B. (1979) Fundamental difference between the molecular interactions of agonists and antagonists with β-adrenergic receptor. Nature 281, 114– 117. Weissman B. A., Bolger G. T., Isaac L., Paul S. M., and Skolnick P. (1984) Characterization of the binding of [3H]Ro 5-4864, a convulsant benzodiazepine, to guinea pig brain. J. Neurochem. 42, 969– 975. Weizman R. and Gavish M. (1989) Chronic diazepam treatment induces an increase in peripheral benzodiazepine binding sites. Clin. Neuropharmacol. 12, 346– 351. Weizman R., Tanne Z., Granek M., Karp L., Golomb M., Tyano S., and Gavish M. (1987) Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. Eur. J. Pharmacol. 138, 289– 292. Weizman A., Bidder M., Fares F., and Gavish M. (1990) Food deprivation modulates γ-aminobutyric acid receptors and peripheral benzodiazepine binding sites in rats. Brain Res. 535, 96– 100. Weizman A., Amiri Z., Katz Y., Snyder S. H., and Gavish M. (1991) Testosterone prevents castration-induced reduction in peripheral benzodiazepine receptors in Cowper's gland and adrenal. Brain Res. (in press). Zavala F. and Lenfant M. (1988) Ca2+-channel blockers modulate the oxidative burst induced with arachidonic acid in macrophage-like P 338D1 cells: interaction with peripheral benzodiazepines. Int. J. Immunopharmacol. 10, 531– 536. Citing Literature Volume58, Issue5May 1992Pages 1589-1601 ReferencesRelatedInformation
Referência(s)